Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising developments across numerous health-related and industrial apps. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, much more dependable substitute for therape